Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FDA
FDA
Sarepta’s disappointing data put the FDA in a difficult spot
Stat
Tue, 10/31/23 - 10:16 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
DMD
FDA
gene therapy
Tracking the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy
BioPharma Dive
Tue, 10/31/23 - 10:13 am
FDA
Vertex Pharmaceuticals
CRISPR
sickle cell disease
exa-cel
Sarepta gene therapy for Duchenne misses main goal of key study
BioPharma Dive
Mon, 10/30/23 - 08:17 pm
Sarepta Therapeutics
gene therapy
Duchenne Muscular Dystrophy
clinical trials
FDA
Elevidys
FDA Flags Off-Target Effects of Vertex, CRISPR’s Sickle Cell Therapy Ahead of Adcomm
BioSpace
Mon, 10/30/23 - 08:09 pm
Vertex Pharmaceuticals
exa-cel
CRISPR
sickle cell disease
FDA
PTC's plans crash into regulatory reality as FDA demands data on 2 candidates, delaying filing
Fierce Biotech
Fri, 10/27/23 - 11:49 am
PTC Therapeutics
FDA
Friedreich's Ataxia
FDA Approves Novel Corticosteroid Treatment Option for DMD Patients
BioSpace
Fri, 10/27/23 - 11:47 am
Santhera Pharmaceuticals
Catalyst Pharmaceuticals
Agamree
FDA
DMD
Duchenne Muscular Dystrophy
Alnylam Publishes Phase III ATTR-CM Data for Patisiran After FDA Rejection
BioSpace
Thu, 10/26/23 - 10:39 am
Alnylam
Patisiran
clinical trials
FDA
ATTR with cardiomyopathy
Servier’s Tibsovo Gets FDA Approval as First Targeted Therapy for MDS
BioSpace
Wed, 10/25/23 - 09:41 am
Servier
Tibsovo
MDS
FDA
FDA approves breast reconstruction trial using human ADM
Clinical Trials Arena
Tue, 10/24/23 - 07:45 pm
Medtech
breast reconstruction
MTF Biologics
FDA
IDE
FlexHD Pliable
human acellular dermal matrix
AZ seeks FDA okay for first self-administered flu vaccine
Pharmaphorum
Tue, 10/24/23 - 10:03 am
AstraZeneca
FDA
FluMist Quadrivalent
vaccines
flu vaccines
self-administered vaccines
BrainStorm lays off 30% of staff, slimming down for yet another bid to get ALS cell therapy to market
Fierce Biotech
Tue, 10/24/23 - 09:53 am
BrainStorm Cell Therapeutics
layoffs
FDA
ALS
NurOwn
Biora submits updated IND application for ulcerative colitis drug/device trial
Clinical Trials Arena
Tue, 10/24/23 - 09:37 am
Biora Therapeutics
ulcerative colitis
BT-600
FDA
drug-device combos
Insulet Omnipod 5 iPhone App FDA Cleared
Medical Devices and Diagnostics Industry
Mon, 10/23/23 - 05:09 pm
Medtech
Insulet
Omnipod 5
FDA
insulin delivery
diabetes
Verve gets FDA green light to run base editing study in US
BioPharma Dive
Mon, 10/23/23 - 05:01 pm
Verve Therapeutics
FDA
gene editing
heart disease
clinical trials
Intellia Gets FDA Clearance to Start First Ever Phase III Trial for an In Vivo CRISPR Drug
Xtalks
Mon, 10/23/23 - 10:31 am
Intellia Therapeutics
FDA
NTLA-2001
ATTR with cardiomyopathy
BioMarin's dwarfism therapy gets FDA nod for expanded use
Reuters
Mon, 10/23/23 - 09:08 am
BioMarin Pharmaceutical
short-limbed dwarfism
FDA
Voxzogo
Pfizer beats out GSK with FDA nod for first 5-in-1 meningitis shot
Fierce Pharma
Sun, 10/22/23 - 06:16 pm
Pfizer
GSK
vaccines
FDA
Penbraya
meningococcal disease
UCB Wins FDA Approval for Plaque Psoriasis Therapy After Regulatory Setbacks
BioSpace
Thu, 10/19/23 - 10:15 am
UCB
bimekizumab
psoriasis
FDA
Bimzelx
SeaStar Medical Nabs Breakthrough Device Designation for Hepatorenal Syndrome
Medical Devices and Diagnostics Industry
Wed, 10/18/23 - 07:47 pm
Medtech
SeaStar Medical Holdings
FDA
hepatorenal syndrome
selective cytopheretic device
BrainStorm eyes FDA meeting to find path for rejected ALS drug after withdrawing application
Fierce Biotech
Wed, 10/18/23 - 11:20 am
BrainStorm Cell Therapeutics
ALS
FDA
NurOwn
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »